128 related articles for article (PubMed ID: 26505456)
41. Newly identified biomarkers for detecting circulating tumor cells in lung adenocarcinoma.
Man Y; Cao J; Jin S; Xu G; Pan B; Shang L; Che D; Yu Q; Yu Y
Tohoku J Exp Med; 2014 Sep; 234(1):29-40. PubMed ID: 25175030
[TBL] [Abstract][Full Text] [Related]
42. Transcription expression and clinical significance of TTF-1 mRNA in pleural effusion of patients with lung cancer.
Jiang B; Wu GP; Zhao YJ; Wang SC
Diagn Cytopathol; 2008 Dec; 36(12):849-54. PubMed ID: 18855882
[TBL] [Abstract][Full Text] [Related]
43. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
[TBL] [Abstract][Full Text] [Related]
44. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
[TBL] [Abstract][Full Text] [Related]
45. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
46. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
47. [Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer].
Wang J; Liu X; Jiang W
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):289-92. PubMed ID: 11783109
[TBL] [Abstract][Full Text] [Related]
48. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.
Sheu CC; Chang MY; Chang HC; Tsai JR; Lin SR; Chang SJ; Hwang JJ; Huang MS; Chong IW
Oncology; 2006; 70(3):203-11. PubMed ID: 16809939
[TBL] [Abstract][Full Text] [Related]
49. [Detection of telomerase hTERT gene expression of exfoliated cell in broncho-alveolar lavage fluid].
Ma G; Gao JS; Tong M; Xiong JG; He YS; Rong TH
Ai Zheng; 2002 May; 21(5):533-5. PubMed ID: 12452048
[TBL] [Abstract][Full Text] [Related]
50. Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid.
Kahn N; Meister M; Eberhardt R; Muley T; Schnabel PA; Bender C; Johannes M; Keitel D; Sültmann H; Herth FJ; Kuner R
J Thorac Oncol; 2012 Jun; 7(6):1001-8. PubMed ID: 22588153
[TBL] [Abstract][Full Text] [Related]
51. Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR.
Lou J; Ben S; Yang G; Liang X; Wang X; Ni S; Han B
PLoS One; 2013; 8(12):e80458. PubMed ID: 24324600
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer.
Cheng M; Chen Y; Yu X; Tian Z; Wei H
BMC Cancer; 2008 May; 8():156. PubMed ID: 18513434
[TBL] [Abstract][Full Text] [Related]
53. A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer.
Wang L; Wang LE; Mao L; Spitz MR; Wei Q
Clin Cancer Res; 2010 Jul; 16(14):3779-85. PubMed ID: 20466886
[TBL] [Abstract][Full Text] [Related]
54. Detection of hTERT mRNA in peripheral blood and its implication for diagnosis of early stage postoperative endometrial cancer micrometastasis.
Liang J; Yin G; Chen M; Wu A
Panminerva Med; 2016 Sep; 58(3):206-10. PubMed ID: 27120048
[TBL] [Abstract][Full Text] [Related]
55. Template-ready PCR method for detection of human telomerase reverse transcriptase mRNA in sputum.
Chen E; Bao Z; Zhen H; Chen Y; Wu C; Zhang J; Xu H; Ding Y; Wang Y; Yu F; Lu G; Chen J; Zhang P; Yao Y; Liu S; Xuan J; Xia F; Chen R; Su B; Zhou J
Anal Biochem; 2019 Jul; 577():34-41. PubMed ID: 30991019
[TBL] [Abstract][Full Text] [Related]
56. The expression of circulating tumor cells in peripheral blood of patients with non-small cell lung cancer and its detection.
Bu XM; Xu FF; Ma J; Jiang B
J Biol Regul Homeost Agents; 2018; 32(4):843-849. PubMed ID: 30043565
[TBL] [Abstract][Full Text] [Related]
57. Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected].
Mitas M; Hoover L; Silvestri G; Reed C; Green M; Turrisi AT; Sherman C; Mikhitarian K; Cole DJ; Block MI; Gillanders WE
J Mol Diagn; 2003 Nov; 5(4):237-42. PubMed ID: 14573783
[TBL] [Abstract][Full Text] [Related]
58. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer.
Liao J; Yu L; Mei Y; Guarnera M; Shen J; Li R; Liu Z; Jiang F
Mol Cancer; 2010 Jul; 9():198. PubMed ID: 20663213
[TBL] [Abstract][Full Text] [Related]
59. Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients.
Hayes DC; Secrist H; Bangur CS; Wang T; Zhang X; Harlan D; Goodman GE; Houghton RL; Persing DH; Zehentner BK
Anticancer Res; 2006; 26(2B):1567-75. PubMed ID: 16619573
[TBL] [Abstract][Full Text] [Related]
60. Identification of genes associated with non-small-cell lung cancer promotion and progression.
Bankovic J; Stojsic J; Jovanovic D; Andjelkovic T; Milinkovic V; Ruzdijic S; Tanic N
Lung Cancer; 2010 Feb; 67(2):151-9. PubMed ID: 19473719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
